Interestingly, also in these neurodegenerative diseases activation of RhoA has been implied [31], suggesting that the RhoA-induced suppression of the HSR may represent a more general feature of diseases related to proteotoxicity. This evidence concerns the gene RHOA and neurodegenerative disease.